Thrombin inhibition and coronary artery thrombolysis.
Yao
S K
SK
Department of Internal Medicine, University of Texas Medical School, Houston.
McNatt
J M
JM
Anderson
H V
HV
Eidt
J F
JF
Cui
K X
KX
Golino
P
P
Glas-Greenwalt
P
P
Maraganore
J M
JM
Buja
L M
LM
Willerson
J T
JT
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D003328:Coronary Thrombosis / Q000097:blood / Q000188:drug therapy*; D004285:Dogs; D006493:Heparin / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives; D015425:Myocardial Reperfusion; D010446:Peptide Fragments / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D013917:Thrombin / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D006629:Hirudins; D010446:Peptide Fragments; C062510:hirugen; D006493:Heparin; D013917:Thrombin; D010959:Tissue Plasminogen Activator